Kevin J Yeaman sold $2.5M of DLB
President and CEO at Dolby Laboratories, Inc.. 36,699 shares at an average of $66.91, traded Nov 24, 2025, filed Nov 26, 2025.
Score components
- +25RoleCEO
- +25Trade size$2.5M at market
- +5Share of holdings soldSold 24% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-301000, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 24, 2025 | MOption exercise Class A Common Stockindirect: By a trust10b5-1 | +25,000 | $45.50 | $1.1M | 139,725 | Nov 26, 2025 |
| Nov 24, 2025 | MOption exercise Class A Common Stockindirect: By a trust10b5-1 | +11,699 | $64.60 | $756k | 151,424 | Nov 26, 2025 |
| Nov 24, 2025 | SOpen-market sale Class A Common Stockindirect: By a trust10b5-1 | -36,699 | $66.91 | $2.5M | 114,725 | Nov 26, 2025 |
| Nov 26, 2025 | GGift Class A Common Stockindirect: By a trust10b5-1 | -16,348 | $0.00 | $0 | 98,377 | Nov 26, 2025 |
| Nov 24, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivativeindirect: By a trust10b5-1 | -25,000 | $0.00 | $0 | 10,615 | Nov 26, 2025 |
| Nov 24, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivativeindirect: By a trust10b5-1 | -11,699 | $0.00 | $0 | 23,752 | Nov 26, 2025 |
Related signals
Other insiders at Dolby Laboratories, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $451k 7,667 shares | -4% | |
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $468k 7,667 shares | -6% | |
| 22Weak | Dolby Laboratories, Inc. | Mark Andrew Sherman EVP, Gen. Counsel & Secretary | $775k 11,600 shares | -14% | |
| 40Moderate | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $2.2M 33,517 shares | -25% | |
| 28Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $500k 7,273 shares | -6% | |
| 40Moderate | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $2.3M 34,367 shares | -26% | |
| 9Weak | Dolby Laboratories, Inc. | Mark Andrew Sherman EVP, Gen. Counsel & Secretary | $304k 4,500 shares | -7% | |
| 32Weak | Dolby Laboratories, Inc. | Tony A Prophet director | $224k 3,300 shares | -27% | |
| 46Moderate | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $408k 6,164 shares | -5% | |
| 22Weak | Dolby Laboratories, Inc. | Shriram Revankar SVP, Advanced Technology Group | $197k 3,000 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.